Thermo Fisher Scientific (TMO) Life Sciences Solutions — Research and development expenses — Quarterly & Annual

Screener

Other segment segments

Analytical Instruments

$139M+1.5%

Specialty Diagnostics

$44M-2.2%

Laboratory Products and Biopharma Services

$15M+15.4%

Similar metrics at other companies

REZIProducts and Solutions — Research and development expenses

$36M+33.3%

SOL

SOLSRefrigerants & Applied Solutions — Research and development expenses

$18M+38.5%

KTOSKratos Government Solutions — Research and development expenses

$9.9M+3.1%

TWIConsumer — Research and development expenses

$1.01M+13.3%

TWIAgriculture — Research and development expenses

$1.49M+9.7%

BAXPharmaceuticals — Research and development expenses

$22M-15.4%

Other financials

Income statement

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

Market cap$213.65B+26.0%

Enterprise value$248.77B+22.9%

P/E30.7×+4.9×

P/S4.8×-0.9×

Profitability

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000097745-26-000092

(In millions)	Life Sciences Solutions	Analytical Instruments	Specialty Diagnostics	Laboratory Products and Biopharma Services	Total
Segment Income
Cost of revenues	1,004	876	657	4,757
Selling, general, and administrative expenses	496	313	177	597
Research and development expenses	131	139	44	15
Other segment items	50	34	(49)	(110)
Segment income	954	355	313	778	2,399
Unallocated amounts
Cost of revenues adjustments					(14)

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's life sciences solutions — research and development expenses?: Thermo Fisher Scientific (TMO) reported life sciences solutions — research and development expenses of $131M in Q1 2026.
How has Thermo Fisher Scientific's life sciences solutions — research and development expenses changed year-over-year?: Thermo Fisher Scientific's life sciences solutions — research and development expenses decreased by 5.8% year-over-year, from $139M to $131M.
What does life sciences solutions — research and development expenses mean?: Expenditures dedicated to the discovery and development of new products, technologies, and scientific solutions within the Life Sciences segment. This investment is critical for maintaining long-term competitive advantage and innovation pipelines.

Ask your AI about Thermo Fisher Scientific's life sciences solutions — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk